Assessing activity of pediatric Crohn's disease: Which index to use?

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation Tuula Halttunen, Markku Mäki.
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease Richard N. Fedorak, *, Alfred Gangl, ‡, Charles.
Kamyar Kalantar-Zadeh  Kidney International 
Colloquium on Therapy of Right Heart Failure
Copyright © American Speech-Language-Hearing Association
Volume 133, Issue 2, Pages (August 2007)
It's time to bring the best and brightest back to gastroenterology!
From: Coronary Artery Plaque Burden and Perioperative Cardiac Risk
Air Pollution and Chest Disease
Development and validation of a self-report symptom inventory to assess the severity of oral-pharyngeal dysphagia  Karen L. Wallace, Sue Middleton, Ian.
Anti–tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: A case report  Philip V. Hassard, Scott W. Binder, Viera.
Diagnosis of irritable bowel syndrome
Leptin, obesity, and liver disease
Volume 115, Issue 6, Pages (December 1998)
Volume 133, Issue 2, Pages (August 2007)
Dynamics of serum procalcitonin in patients after major neurosurgery
Chad A. Morse, Stuart F. Quan, Mary Z
Self reported adverse effects of mono and polytherapy for epilepsy
Appendectomy is followed by increased risk of Crohn's disease
Kyung W. Noh, Surakit Pungpapong, Michael B. Wallace, Timothy A
Seasonal variation of acne and psoriasis: A 3-year study using the Physician Global Assessment severity scale  Vanessa Lindsay Pascoe, MD, Alexandra Boer.
Antje Timmer*, Lloyd R. Sutherland*,‡, Francois Martin§ 
Association of Trough Serum Infliximab to Clinical Outcome After Scheduled Maintenance Treatment for Crohn’s Disease  Elana A. Maser, Renata Villela,
Bisphosphonate Therapy for Reduced Bone Mineral Density in Children with Chronic Graft-versus-Host Disease  Paul A. Carpenter, Paul Hoffmeister, Charles.
Volume 130, Issue 2, Pages (February 2006)
An evidence-based medicine approach to studies of diagnostic tests: Assessing the validity of virtual colonoscopy  Brooks D. Cash, Philip Schoenfeld,
Volume 120, Issue 4, Pages (March 2001)
Kamyar Kalantar-Zadeh  Kidney International 
Francisco A. Sylvester, Scott Leopold, Miriam Lincoln, Jeffrey S
Measuring acute postoperative pain using the visual analog scale: the minimal clinically important difference and patient acceptable symptom state  P.S.
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
Volume 119, Issue 6, Pages (December 2000)
James E. Everhart, Meena Khare, Michael Hill, Kurt R. Maurer 
Volume 122, Issue 7, Pages (June 2002)
Volume 69, Issue 2, Pages (January 2006)
Measuring quality of recovery-15 after day case surgery
Cannabis Induces a Clinical Response in Patients With Crohn's Disease: A Prospective Placebo-Controlled Study  Timna Naftali, Lihi Bar-Lev Schleider,
AGA technical review on nonalcoholic fatty liver disease
A. Abdelnasser, B. Abdelhamid, A. Elsonbaty, A. Hasanin, A. Rady 
Saliva cyclic GMP increases during anaesthesia
Antoine Debourdeau, Anne Bozon, Romain Altwegg  Gastroenterology 
Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease  Gerassimos J.
V. Uppal, G. Fletcher, J. Kinsella  British Journal of Anaesthesia 
Volume 149, Issue 6, Pages (November 2015)
Kim G. Smolderen, PhD, Aline J
Volume 121, Issue 5, Pages (November 2001)
Thomas M. Gill, MD, Evelyne A. Gahbauer, MD, MPH, Peter H
Volume 17, Issue 2, Pages (February 1950)
Higher risk of hospitalization among females with cystic fibrosis
Volume 80, Issue 12, Pages (December 2011)
Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity  Severine Vermeire, Stefan Schreiber,
Volume 64, Issue 1, Pages (July 2003)
Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews  Emily C. Merkel, Sandra A. Mitchell,
AGA technical review on osteoporosis in gastrointestinal diseases
Volume 144, Issue 3, Pages (March 2013)
Volume 117, Issue 3, Pages (September 1999)
Volume 76, Issue 8, Pages (October 2009)
Differential modulation of interleukin‐6 and interleukin‐10 by diclofenac in patients undergoing major surgery  A.M. Mahdy, H.F. Galley, M.A. Abdel‐Wahed,
Volume 132, Issue 3, Pages (March 2007)
Diastolic function predicts survival after renal revascularization
Dennis L. Hart, PhD, PT, Benjamin D. Wright, PhD 
Michelle Maria Pietzak  Gastroenterology 
This Month in AJKD American Journal of Kidney Diseases
Reply Gastroenterology
Choosing outcome variables: global assessment and diaries
The Journal of Thoracic and Cardiovascular Surgery
Use of a high-fidelity simulator to develop testing of the technical performance of novice anaesthetists†   F.C. Forrest, M.A. Taylor, K. Postlethwaite,
Medical Therapy for Refractory Pediatric Crohn’s Disease
Volume 121, Issue 2, Pages (August 2001)
Presentation transcript:

Assessing activity of pediatric Crohn's disease: Which index to use? Anthony Otley, Hester Loonen, Namita Parekh, Mary Corey, Philip M. Sherman, Anne M. Griffiths  Gastroenterology  Volume 116, Issue 3, Pages 527-531 (March 1999) DOI: 10.1016/S0016-5085(99)70173-3 Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 1 Box-and-whisker plot of PCDAI scores among patients categorized by physician global assessment of disease activity. The box shows the 25th percentile, median, and 75th percentile. The whiskers show the range of the data. The PCDAI score could not be calculated (laboratory value missing) for 3 patients (1 mild, 2 moderate). *Cut score for inactive disease (<10).5 **Cut score for moderate/severe disease (>30).5 Gastroenterology 1999 116, 527-531DOI: (10.1016/S0016-5085(99)70173-3) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 2 Box-and-whisker plot of CDAI scores among patients categorized by physician global assessment of disease activity. The box shows the 25th percentile, median, and 75th percentile. The whiskers show the range of the data. The CDAI score could not be calculated (diary not available) for 1 patient (moderate). *CDAI cut score for inactive disease (<150).2 Gastroenterology 1999 116, 527-531DOI: (10.1016/S0016-5085(99)70173-3) Copyright © 1999 American Gastroenterological Association Terms and Conditions